NAGE Niagen Bioscience, Inc.: institutional ownership and insider trading
145 funds reported holding $124M of Niagen Bioscience, Inc. in their latest 13F filings; in Q2 2026 funds net sold $16.1M, with 23 new positions and 27 funds selling out; over the last 12 months insiders bought $45.6K and sold $0 on the open market; over its last four quarters it reported revenue of $129M and net income of $16.0M.
NAGE revenue and earnings
- Quarter ended Jun 30, 2026: revenue $29.8M, net income $963K, EPS 0.01
- Quarter ended Mar 31, 2026: revenue $31.5M, net income $6.32M, EPS 0.07
- Quarter ended Dec 31, 2025: revenue $33.8M, net income $4.13M, EPS 0.05
- Quarter ended Sep 30, 2025: revenue $34.0M, net income $4.58M, EPS 0.05
Famous investors holding NAGE
- Ken Griffin (Citadel Advisors): $2.15M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.10M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $879K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $319K, 0.0% of the portfolio
Largest institutional holders of NAGE
- VANGUARD GROUP INC — $20.9M
- BlackRock, Inc. (BLK) — $13.3M
- SteelPeak Wealth, LLC — $10.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.85M
- Tieton Capital Management, LLC — $6.41M
- Qube Research & Technologies Ltd — $5.18M
- GEODE CAPITAL MANAGEMENT, LLC — $4.72M
- UBS Group AG (UBS) — $4.09M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $4.03M
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — $3.74M
Recent NAGE insider trades
- Nov 14, 2025: Pamir Ozan bought 6,685 shares ($45.6K)
- Mar 7, 2025: Lopez Carlos Luis bought 273 shares ($2.15K)
- Dec 13, 2024: Jaksch Frank L Jr sold 37,161 shares ($230K)
- Nov 22, 2024: Pamir Ozan bought 2,907 shares ($21.4K)
5%+ owners
- BlackRock, Inc.: 5.2% (Schedule 13G, filed Jul 29, 2026)
Who owns the most NAGE stock?
The largest institutional holders of Niagen Bioscience, Inc. in the latest 13F filings are VANGUARD GROUP INC ($20.9M), BlackRock, Inc. (BLK) ($13.3M), SteelPeak Wealth, LLC ($10.4M).
Are insiders buying or selling NAGE?
Over the last 12 months insiders bought $45.6K and sold $0 of Niagen Bioscience, Inc. stock on the open market (SEC Form 4).
Which famous investors own NAGE?
Ken Griffin, Renaissance Technologies, Izzy Englander, D. E. Shaw.
What was NAGE's revenue last quarter?
Niagen Bioscience, Inc. reported revenue of $29.8M for the quarter ended June 30, 2026, with net income of $963K.
Which ETFs hold NAGE?
2 ETFs and mutual funds hold it among their top 100 positions, including GAMNX, LOPP.